Research Topics
Genomes and GenesSpecies | G I MurraySummaryAffiliation: University of Aberdeen Country: UK Publications
| Collaborators
|
Detail Information
Publications
The roles of heterogeneous nuclear ribonucleoproteins in tumour development and progressionBrian Carpenter
Department of Pathology, University of Aberdeen, Foresterhill, Aberdeen AB25 2ZD, UK
Biochim Biophys Acta 1765:85-100. 2006..The different stages of tumour development that are potentially regulated by the hnRNPs along with their aberrant expression profiles in tumour tissues will also be discussed...
Generation Scotland: the Scottish Family Health Study; a new resource for researching genes and heritabilityBlair H Smith
University of Aberdeen, Department of General Practice and Primary Care, Foresterhill Health Centre, Westburn Road, Aberdeen, UK
BMC Med Genet 7:74. 2006....
APRIL is a novel clinical chemo-resistance biomarker in colorectal adenocarcinoma identified by gene expression profilingRussell D Petty
University of Aberdeen, UK
BMC Cancer 9:434. 2009..The aim was to identify novel 5FU resistance mechanisms and qualify these as candidate biomarkers and therapeutic targets...
Matrix metalloproteinase-1 is associated with poor prognosis in oesophageal cancerG I Murray
Department of Pathology, University of Aberdeen, U K
J Pathol 185:256-61. 1998..02). The identification of individual MMPs in oesophageal cancer provides a rational basis for use in the treatment of oesophageal cancer of MMP inhibitors which are currently undergoing clinical trial...
The role of cytochrome P450 in tumour development and progression and its potential in therapyG I Murray
Department of Pathology, University of Aberdeen, Aberdeen, UK
J Pathol 192:419-26. 2000..The tumour-specific expression of P450 provides the basis for the development of novel diagnostic and therapeutic strategies...
Profiling the expression of cytochrome P450 in breast cancerGraeme I Murray
Division of Applied Medicine, School of Medicine and Dentistry, University of Aberdeen, Aberdeen, UK
Histopathology 57:202-11. 2010..The aim was to define the P450 expression profile in breast cancer and establish the significance of P450 expression in this tumour type...
Regulation, function, and tissue-specific expression of cytochrome P450 CYP1B1G I Murray
Department of Pathology, University of Aberdeen, Aberdeen, AB25 2ZD, United Kingdom
Annu Rev Pharmacol Toxicol 41:297-316. 2001..In humans CYP1B1 is overexpressed in tumor cells, and this has important implications for tumor development and progression and the development of anticancer drugs specifically activated by CYP1B1...
An overview of laser microdissection technologiesGraeme I Murray
Department of Pathology, University of Aberdeen, Foresterhill, Aberdeen AB25 2ZD, Scotland, UK
Acta Histochem 109:171-6. 2007..Through their appropriate application they have provided significant new insights into cell biology and pathology...
Tumor-specific expression of cytochrome P450 CYP1B1G I Murray
Department of Pathology, University of Aberdeen, Foresterhill, United Kingdom
Cancer Res 57:3026-31. 1997..These results provide the basis for the development of novel methods of cancer diagnosis based on the identification of CYP1B1 in tumor cells and the development of anticancer drugs that are selectively activated in tumors by CYP1B1...
Characterization and over-expression of chaperonin t-complex proteins in colorectal cancerC Coghlin
Department of Pathology, University of Aberdeen, Aberdeen, UK
J Pathol 210:351-7. 2006..05). These results show that both TCP1 beta and TCP1 epsilon are over-expressed in colorectal cancer and indicate a role for TCP1 beta and TCP1 epsilon in colorectal cancer progression...
Expression of matrix metalloproteinases 1, 2, 9 and their tissue inhibitors in stage II non-small cell lung cancer: implications for MMP inhibition therapyS C Pritchard
Department of Medicine and Therapeutics, University of Aberdeen, Aberdeen AB25 2ZD, UK
Oncol Rep 8:421-4. 2001..These results suggest that a broad spectrum MMP inhibitor is worthy of evaluation as a therapeutic method of reducing tumor invasion and metastasis in stage II NSCLC...
Colorectal cancer genomics: evidence for multiple genotypes which influence survivalP H Rooney
Department of Medicine and Therapeutics, University of Aberdeen, Foresterhill, AB25 2ZD, Aberdeen
Br J Cancer 85:1492-8. 2001..Although genomic change in CRC is relevant to the survival of patients with Dukes' C CRC, careful analysis is required to identify cell lines which are representative models of CRC genomics...
Matrix metalloproteinases and their inhibitors in gastric cancerG I Murray
Department of Pathology, University of Aberdeen, UK
Gut 43:791-7. 1998..The matrix metalloproteinases (MMPs) and tissue inhibitors of matrix metalloproteinases (TIMPs) are strongly implicated in tumour invasion and metastasis...
Evaluation of the epidermal growth factor receptor (EGFR) in colorectal tumours and lymph node metastasesJ A McKay
Department of Medicine and Therapeutics, University of Aberdeen, Foresterhill, AB25 2ZD, Aberdeen, UK
Eur J Cancer 38:2258-64. 2002..05). These results indicate that while EGFR overexpression is a common event in colorectal carcinogenesis, it does not influence patient prognosis...
Characterisation and protein expression profiling of annexins in colorectal cancerR Duncan
Department of Pathology, University of Aberdeen, Aberdeen, UK
Br J Cancer 98:426-33. 2008..In conclusion, this study has shown that individual annexins are present in colorectal cancer, specific annexins are overexpressed in colorectal cancer and the annexin expression profile is associated with survival...
Cytochrome P450 CYP3A in human renal cell cancerG I Murray
Department of Pathology, University of Aberdeen, Foresterhill, UK
Br J Cancer 79:1836-42. 1999..The presence of CYP3A in renal cell cancer might be important in the metabolic potentiation as well as the detoxification of chemotherapeutic agents used to renal cancer...
Expression of cell cycle control proteins in primary colorectal tumors does not always predict expression in lymph node metastasesJ A McKay
Department of Medicine and Therapeutics, University of Aberdeen, Institute of Medical Sciences, Foresterhill, Aberdeen, Scotland, United Kingdom
Clin Cancer Res 6:1113-8. 2000..In addition, PCNA-labeling indices between paired samples were neither consistently higher nor lower, suggesting that the proliferative capacity of tumor cells is not directly related to their ability to metastasize...
Enhanced expression of cytochrome P450 in stomach cancerG I Murray
Department of Pathology, University of Aberdeen, Foresterhill, UK
Br J Cancer 77:1040-4. 1998....
Liver fatty acid binding protein expression in colorectal neoplasiaL C Lawrie
Department of Pathology, University of Aberdeen, Foresterhill, Aberdeen, Foresterhill AB25 2ZD, UK
Br J Cancer 90:1955-60. 2004..This study demonstrates that loss of L-FABP occurs at the adenoma stage of colorectal tumour development and also indicates that L-FABP is a marker of colorectal cancer differentiation...
Cytochrome P450 CYP1B1 over-expression in primary and metastatic ovarian cancerM C McFadyen
Departments of Pathology, Obstetrics and Gynaecology, Medicine and Therapeutics, Molecular and Cell Biology, University of Aberdeen, Foresterhill, Aberdeen, AB25 2ZD, UK
Br J Cancer 85:242-6. 2001..005 Spearman's rank correlation test). In contrast no detectable CYP1B1 was found in normal ovary...
Heterogeneous nuclear ribonucleoprotein K is over expressed, aberrantly localised and is associated with poor prognosis in colorectal cancerB Carpenter
Department of Pathology, University of Aberdeen, Foresterhill, Aberdeen AB25 2ZD, UK
Br J Cancer 95:921-7. 2006..There was no correlation between hnRNP K and p53 expression, however, patients who presented tumours that were positive for hnRNP K and p53 had a poorer survival outcome (P=0.045)...
Cytochrome P450 CYP1B1 protein expression: a novel mechanism of anticancer drug resistanceM C McFadyen
Department of Pathology, University of Aberdeen, Foresterhill, Aberdeen AB25 2ZD, UK
Biochem Pharmacol 62:207-12. 2001..This study is the first to indicate that the presence of CYP1B1 in cells decreases their sensitivity to the cytotoxic effects of a specific anticancer drug...
Human CYP1B1 and anticancer agent metabolism: mechanism for tumor-specific drug inactivation?B Rochat
Department of Medicine and Therapeutics, University of Aberdeen, Aberdeen, Scotland, UK
J Pharmacol Exp Ther 296:537-41. 2001..The results obtained indicate that several anticancer agents inhibit CYP1B1 activity. Drug inactivation by CYP1B1 may represent a novel mechanism of resistance, influencing the clinical outcome of chemotherapy...
c-erbB-2 is not a major factor in the development of colorectal cancerJ A McKay
Department of Medicine and Therapeutics, University of Aberdeen, Institute of Medical Sciences, Foresterhill, Aberdeen AB25 2Z, UK
Br J Cancer 86:568-73. 2002..05 in each case), suggesting that c-erbB-2 is not a prognostic marker in colorectal cancer...
Analysis of uracil DNA glycosylase in human colorectal cancerC Dusseau
Department of Medicine and Therapeutics, Aberdeen Royal Infirmary, University of Aberdeen, UK
Int J Oncol 18:393-9. 2001..The high tumor:normal tissue ratio supports further interest in base excision repair, through UDG, as a potential source of fluoropyrimidine resistance in colorectal cancer...
Application of laser capture microdissection and proteomics in colon cancerL C Lawrie
Department of Pathology, University of Aberdeen, Foresterhill, Aberdeen, AB25 2ZD, UK
Mol Pathol 54:253-8. 2001..CONCLUSION: A method for performing two dimensional gel electrophoresis and mass spectrometry using laser capture microdissected tissue has been developed...
p53 protein expression in a population-based series of primary vulval squamous cell carcinoma and immediate adjacent field changeD T McConnell
Department of Pathology, University of Aberdeen, Scotland
Gynecol Oncol 67:248-54. 1997..Our aim was to study correlations between survival, disease recurrence, and p53 protein expression in a well defined population-based series of vulval squamous cell carcinoma and immediate adjacent epithelial skin changes...
Matrix metalloproteinase 13 activity is associated with poor prognosis in colorectal cancerM F Leeman
Department of Pathology, University of Aberdeen, Foresterhill, Aberdeen AB25 2ZD, UK
J Clin Pathol 55:758-62. 2002..02). CONCLUSIONS: These results show that MMP-13 is frequently present and active in colorectal cancer and suggest that the activity of MMP-13 is associated with poorer survival in colorectal cancer...
CYP3A4 and VDR gene polymorphisms and the risk of prostate cancer in men with benign prostate hyperplasiaM T Tayeb
Department of Medicine and Therapeutics, Institute of Medical Sciences, University of Aberdeen, Foresthill, UK
Br J Cancer 88:928-32. 2003..43; 95% CI=0.99-11.77). While independent confirmation is required in further studies, these results provide a potential tool to assist prediction strategies for this important disease...
COX-2 expression in sporadic colorectal adenomatous polyps is linked to adenoma characteristicsM H McLean
GI Research Group, Department of Medicine and Therapeutics, University of Aberdeen, Aberdeen, UK
Histopathology 52:806-15. 2008..To assess cyclooxygenase-2 (COX-2) expression in sporadic colonic adenomas and to explore the association of COX-2 positivity with adenoma characteristics linked to increased risk of malignant transformation...
The role of annexins in tumour development and progressionS Mussunoor
Department of Pathology, University of Aberdeen, UK
J Pathol 216:131-40. 2008..Changes in the expression of individual annexins are associated with particular types of tumour and hence the annexins may also be useful biomarkers in the clinic...
Spot the differences: proteomics in cancer researchL C Lawrie
University of Aberdeen, Foresterhill, UK
Lancet Oncol 2:270-7. 2001..This new technology will give much-needed insight into the molecular mechanisms of tumour development and progression...
Analysis of key cell-cycle checkpoint proteins in colorectal tumoursJudith A McKay
Department of Medicine and Therapeutics, University of Aberdeen, Foresterhill, Aberdeen, AB25 2ZD, UK
J Pathol 196:386-93. 2002..0266), but it was not an independent predictor of survival. These results suggest that loss of control of cell-cycle checkpoints is a common occurrence in colorectal tumours and may be an important therapeutic target...
Immunohistochemistry of neurone specific enolase with gamma subunit specific anti-peptide monoclonal antibodiesG I Murray
Department of Pathology, University of Aberdeen
J Clin Pathol 46:993-6. 1993....
Thymidine phosphorylase and dihydropyrimidine dehydrogenase protein expression in colorectal cancerE S Collie-Duguid
Department of Medicine and Therapeutics, University of Aberdeen, Aberdeen, Scotland
Int J Cancer 94:297-301. 2001..This suggests the presence of co-ordinated regulation of these pyrimidine metabolic enzymes and offers a strategy for optimising the use of pyrimidine-based chemotherapy...
Amplification of fluorescent in situ hybridisation signals in formalin fixed paraffin wax embedded sections of colon tumour using biotinylated tyramideJ A McKay
Department of Medicine and Therapeutics, University of Aberdeen, Institute of Medical Sciences, Foresterhill, UK
Mol Pathol 50:322-5. 1997....
Characterization of dihydropyrimidine dehydrogenase in human colorectal tumoursH L McLeod
Department of Medicine, University of Aberdeen, Foresterhill, UK
Br J Cancer 77:461-5. 1998..As a large degree of the variation in tumour DPD activity is not explained by PMNC activity, more accurate alternatives are needed before DPD activity can be used for targeting 5-FU therapy...
Human papillomavirus 16 infection in adenocarcinoma of the cervixG K Chew
Department of Gynaecology Oncology, Aberdeen Royal Infirmary, Foresterhill, Aberdeen, UK
Br J Cancer 93:1301-4. 2005..014). Women with ACC also had significantly higher HPV DNA copy number per cell compared to the control group (P=0.00007). Higher HPV DNA copy number is associated with risk of developing ACC...
Gene expression profiling in non-small cell lung cancer: from molecular mechanisms to clinical applicationRussell D Petty
Department of Oncology, Aberdeen and Oncology Research Group, Department of Medicine and Therapeutics, University of Aberdeen, Aberdeen, United Kingdom
Clin Cancer Res 10:3237-48. 2004..Taken together, these advances hold the promise of an improved understanding of the molecular biology of NSCLC and its treatment, which in turn will lead to improved outcomes for this deadly disease...
Matrix metalloproteinase/tissue inhibitors of matrix metalloproteinase phenotype identifies poor prognosis colorectal cancersStephanie Curran
Department of Pathology, University of Aberdeen, Aberdeen, United Kingdom
Clin Cancer Res 10:8229-34. 2004..Therefore, to understand their role in tumor invasion, it is necessary to evaluate them collectively...
The candidate oncogene ZNF217 is frequently amplified in colon cancerPatrick H Rooney
Department of Pathology, University of Aberdeen, UK
J Pathol 204:282-8. 2004..There was a trend toward poorer survival in patients whose cancers had either gain or loss of ZNF217...
Expression of Fhit, cell adhesion molecules and matrix metalloproteinases in atypical adenomatous hyperplasia and pulmonary adenocarcinomaKeith M Kerr
Department of Pathology, Aberdeen University Medical School, Aberdeen, UK
J Pathol 203:638-44. 2004..Loss of MMP-2 and TIMP-2 in stromally invasive tumour may reflect a particular role for MMP-2 at the BAC stage, with later down-regulation of this particular enzyme...
Cytochrome P450 1B1: a novel anticancer therapeutic targetMorag C E McFadyen
Robert Gordon University, School of Pharmacy, Schoolhill, Aberdeen, AB10 1FR, UK
Future Oncol 1:259-63. 2005..The therapeutic strategy, which is at the most advanced stage of development, is a CYP1B1-based vaccine which has already successfully completed a Phase I clinical trial...
Cytochrome p450 profile of colorectal cancer: identification of markers of prognosisMeera Kumarakulasingham
Department of Pathology, University of Aberdeen and Auvation, Ltd, Aberdeen, United Kingdom
Clin Cancer Res 11:3758-65. 2005..Several P450s show increased expression in colorectal cancer. High expression of CYP51 or CYP2S1 were associated with poor prognosis and CYP51 is an independent marker of prognosis...
Cytochrome P450 enzymes: novel options for cancer therapeuticsMorag C E McFadyen
Department of Pathology, University of Aberdeen, Aberdeen, United Kingdom
Mol Cancer Ther 3:363-71. 2004..The purpose of this review is to outline the novel therapeutic options and opportunities arising from both enhanced endogenous expression of cytochrome P450 in tumors and cytochrome P450-mediated gene therapy...
Quantitative analysis of the Ah receptor/cytochrome P450 CYP1B1/CYP1A1 signalling pathwayMorag C E McFadyen
Department of Pathology, University of Aberdeen, Aberdeen, AB25 2ZD, UK
Biochem Pharmacol 65:1663-74. 2003..In addition, the expression pattern of CYP1B1 mRNA and protein in the MOG-G-CCM cells highlights this cell line as a potential model for studying CYP1B1 expression in human tissue...
Mortalin is over-expressed by colorectal adenocarcinomas and correlates with poor survivalSinclair R Dundas
Department of Pathology, University of Aberdeen, Aberdeen, UK
J Pathol 205:74-81. 2005..Our experimental approach emphasises the analytical power of combining proteomics with tissue microarray analysis in the context of a well-defined tumour database...
Cytochrome P450 CYP3A5 in the human anterior pituitary glandG I Murray
Department of Pathology, University of Aberdeen, UK
FEBS Lett 364:79-82. 1995..This is the first direct identification of an individual P450 subfamily in the pituitary gland and the presence of CYP3A in the pituitary gland may play a role in regulating growth hormone secretion...
The role of cytochrome P450 in cytotoxic bioactivation: future therapeutic directionsP H Rooney
Department of Pathology, University of Aberdeen, Foresterhill, Aberdeen, AB25 2ZD, UK
Curr Cancer Drug Targets 4:257-65. 2004..Specific activation of pro-drugs by isoforms whose expression or particular catalytic activity is limited to cancer cells offers the possibility of truly targeted chemotherapy with minimized systemic toxicity...
Cytochrome P450 CYP1B1 activity in renal cell carcinomaM C E McFadyen
Department of Pathology, University of Aberdeen, Foresterhill, Aberdeen AB25 2ZD, UK
Br J Cancer 91:966-71. 2004..The presence of detectable CYP1B1, which is capable of metabolising anticancer drugs in tumour cells, highlights a novel target for therapeutic intervention...
Regional distribution of individual forms of cytochrome P450 mRNA in normal adult human brainM C McFayden
Department of Pathology, University of Aberdeen, Foresterhill, UK
Biochem Pharmacol 55:825-30. 1998..The distribution of individual P450s in different regions of human brain is likely to be highly important in determining the response of the brain to toxic foreign compounds...
The matrix metalloproteinase/tissue inhibitor of matrix metalloproteinase profile in colorectal polyp cancersNatalie Jeffery
Department of Pathology, University of Aberdeen, Aberdeen, UK
Histopathology 54:820-8. 2009..Roles in pathways involved in early tumour development are also being identified for this system, and the aim of this study was to define the expression profile of the major MMPs and TIMPs in colorectal polyp cancers...
Topoisomerase I protein expression in primary colorectal cancer and lymph node metastasesAttasit Boonsong
Department of Medicine and Therapeutics and Pathology, University of Aberdeen Institute of Medical Sciences, Aberdeen, Scotland, UK
Hum Pathol 33:1114-9. 2002..Topo I expression now needs to be evaluated in patients undergoing topo I-inhibitor therapy, to better define the role of this protein as a predictive marker...
Tumor transcriptome reveals the predictive and prognostic impact of lysosomal protease inhibitors in non-small-cell lung cancerRussell D Petty
Oncology Research Group, Department of Medicine and Therapeutics, Institute of Medical Sciences, School of Medicine, University of Aberdeen, Aberdeen, nited Kingdom
J Clin Oncol 24:1729-44. 2006....
Genomic instability at the BUB1 locus in colorectal cancer, but not in non-small cell lung cancerR G Jaffrey
Department of Medicine and Therapeutics, Institute of Medical Sciences, University of Aberdeen, Scotland
Cancer Res 60:4349-52. 2000..Additional investigations may shed light on the mechanistic impact of the mitotic spindle checkpoint pathway in colorectal tumor initiation and progression...
Primary colorectal tumour is not an accurate predictor of thymidylate synthase in lymph node metastasisSharon Marsh
Department of Medicine and Therapeutics, Institute of Medical Sciences, University of Aberdeen, Foresterhill, Aberdeen AB25 2ZD, UK
Oncol Rep 9:231-4. 2002..05 in all cases). Discordance in TS protein levels between primary and secondary tumours demonstrates the danger of predicting outcome after chemotherapy in metastatic colorectal cancer from the primary tumour...
Profiling markers of prognosis in colorectal cancerMatthew S Lyall
Department of Pathology, University of Aberdeen, Aberdeen, UK
Clin Cancer Res 12:1184-91. 2006..27; 95% confidence interval, 1.15-4.48; P = 0.004). CONCLUSIONS: This study has identified an immunohistochemical marker profile of colorectal cancer and showed that it is an independent indicator of prognosis in this type of cancer...
Profiling cytochrome P450 expression in ovarian cancer: identification of prognostic markersDiane Downie
Department of Pathology, University of Aberdee, UK
Clin Cancer Res 11:7369-75. 2005..Expression of CYP2A/2B or CYP4Z1 in primary ovarian cancer were independent markers of prognosis...
Laser capture microdissection and PCR for analysis of human papilloma virus infectionKheng Chew
Department of Obstetrics and Gynaecology, University of Aberdeen, UK
Methods Mol Biol 293:295-300. 2005..Our results show that HPV type 16 is present in endocervical adenocarcinoma cells...
An introduction to laser-based tissue microdissection techniquesStephanie Curran
Department of Pathology, University of Aberdeen, UK
Methods Mol Biol 293:3-8. 2005..This chapter provides an overview of the different laser-based microdissection systems and an introduction to the principles involved in the function and applications of these individual systems...
New insights into the roles of matrix metalloproteinases in colorectal cancer development and progressionMatthew F Leeman
Department of Pathology, University of Aberdeen, Aberdeen, UK
J Pathol 201:528-34. 2003....
Loss of sensory and noradrenergic innervation in benign colorectal adenomatous polyps--a putative role of semaphorins 3F and 3AN Graf
Department of Internal Medicine I, University Hospital Regensburg, Regensburg, Germany
Neurogastroenterol Motil 24:120-8, e83. 2012..Nerve fibers can exert trophic/anti-trophic effects on epithelial cells. Substance P (SP) is a pro-proliferative neuropeptide, whereas sympathetic noradrenaline is anti-proliferative at high concentrations...
Gliotoxin stimulates the apoptosis of human and rat hepatic stellate cells and enhances the resolution of liver fibrosis in ratsM C Wright
Department of Molecular and Cell Biology, University of Aberdeen, Institute of Medical Sciences, Foresterhill, Aberdeen, Scotland
Gastroenterology 121:685-98. 2001..Hepatic stellate cells (HSCs) play a pivotal role in liver fibrosis and stimulating their apoptosis could be an effective treatment for liver fibrosis...
CYP3A4 promoter variant is associated with prostate cancer risk in men with benign prostate hyperplasiaMohammed T Tayeb
Department of Medicine and Therapeutics, University of Aberdeen, Foresterhill, Aberdeen, UK
Oncol Rep 9:653-5. 2002..The CYP3A4 variant allele identified men with BPH who are at increased risk of progressing to PRCa (odds ratio 6.3, 95% CI 2.3-17.3), providing a potential tool to assist prediction strategies for this disease...
The structure, regulation, and function of human matrix metalloproteinase-13Matthew F Leeman
Department of Pathology, University of Aberdeen, Foresterhill, UK
Crit Rev Biochem Mol Biol 37:149-66. 2002..This commentary provides a detailed overview of the regulatory mechanisms, structure, and function of human MMP-13 and highlights the key factors involved in the biology of this important molecule...
Cytochrome P450 1B1 expression in glial cell tumors: an immunotherapeutic targetJulia A Barnett
Department of Neurosurgery, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
Clin Cancer Res 13:3559-67. 2007..To evaluate the viability of further research efforts targeting this antigen, we examined the expression of CYP1B1 in glial cell malignancies...
Target validation of cytochrome P450 CYP1B1 in prostate carcinoma with protein expression in associated hyperplastic and premalignant tissueDawn M Carnell
Marie Curie Research Wing, Gray Cancer Institute, Mount Vernon Hospital, Northwood, Middlesex HA6 2JR, United Kingdom
Int J Radiat Oncol Biol Phys 58:500-9. 2004..Spectral imaging microscopy has highlighted differences in CYP1B1 protein expression between different cancers...
Raf kinase inhibitor protein expression in a survival analysis of colorectal cancer patientsFahd Al-Mulla
Kuwait University, Faculty of Medicine, Safat, Kuwait
J Clin Oncol 24:5672-9. 2006..We examined whether RKIP expression in primary colorectal cancers (CRCs) correlates with the risk of metastasis and overall survival...
Vitamin D receptor, HER-2 polymorphisms and risk of prostate cancer in men with benign prostate hyperplasiaMohammed T Tayeb
Department of Medical Sciences, Faculty of Medicine and Medical Sciences, Umm Al Qura University, Makkah, Kingdom of Saudi Arabia
Saudi Med J 25:447-51. 2004..This study used a case-control design to assess the predictive value of 3 polymorphisms in VDR (TaqI and FokI) and HER-2 (Val655Ile) to determine the risk of developing PRCa in patients with BPH...
Cytochrome P450 enzymes and tumor therapyMatthias Lohr
Mol Cancer Ther 3:1503; author reply 1503-4. 2004
